BioClinica looks to tap CROs, sponsors hesitant to adopt cloud tech

By Zachary Brennan

- Last updated on GMT

BioClinica looks to tap CROs, sponsors hesitant to adopt cloud tech
BioClinica is looking to target its new offering to the CROs and sponsors who have yet to adopt a cloud-based solution for the management and delivery of clinical trials.

The company’s recently launched eHealth Cloud comes as CROs have been slow to adopt​ paperless technology systems. The BioClinica tool offers a variety of hosting subscription models to meet the needs of different trials, including public consumer, private cloud, managed cloud, and custom options. 

Andrew Masters, SVP of Global Product Development and Technology at BioClinica, told us that one of the “distinct advantages compared to other cloud offerings on the market​” is that the eHealth Cloud differs a “proven and scalable platform focused on the successful integration and delivery of technologies for use in clinical trials​.” 

BioClinica’s trials platform -- which includes Express EDC, Trident RTSM, Optimizer Supply Forecasting and Simulation, OnPoint CTMS and Compass “Intelligent” Risk-Based Monitoring solution -- will be delivered through the eHealth Cloud. 

Competition​ 

BioClinica will face some fierce competition in the market for cloud-based tech as CROs​ and others​ have already begun adopting solutions from companies such as Medidata and DrugDev​. 

But BioClinica’s Masters told us the cloud tool was released now because of “the rapid expansion and proliferation of applications that can now be delivered within a cloud offering. There are many third-party vendors with clinical trial applications without a means to bring them within the regulated clinical trial space​.” 

He also noted that there are “still many sponsors and CROs that have yet to adopt a cloud-based solution for the management and delivery of clinical trials​” as some “are still concerned by the need to have a solution that is appropriately managed to meet regulatory requirements ─ and one that comes at an affordable cost​.” 

The conservative nature of the trials industry was also cited as a barrier to cloud adoption. 

Last year, BioClinica signed two multi-year contract extensions​ for top pharma companies looking to use its cloud-based services.

Related news

Show more

Related products

show more

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Follow us

Products

View more

Webinars